Clinical Trials Logo

Cervical Cancer Squamous Cell clinical trials

View clinical trials related to Cervical Cancer Squamous Cell.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01899404 Completed - Clinical trials for Cervical Cancer Squamous Cell

MRI FDG PET Imaging Cervix

Start date: October 3, 2012
Phase: N/A
Study type: Interventional

The standard treatment for cervix cancer at Princess Margaret Hospital is external radiation with chemotherapy followed by internal radiation, called brachytherapy. Currently, brachytherapy treatment is planned on a type of Magnetic Resonance Imaging (MRI) called T2-weighted (T2W) MRI. The main purpose of this study is to determine whether the following imaging tests can visualize the tumor better for planning the brachytherapy treatment: 1. special types of MRI called diffusion weighted MRI (DWI) and dynamic-contrast enhanced MRI (DCE-MRI); and 2. an x-ray test called positron emission test (PET) performed with a sugar dye called FDG. MRI-guided brachytherapy is resource-intensive and not widely available.

NCT ID: NCT01539668 Completed - Prevention Clinical Trials

Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas

careHPV
Start date: March 2012
Phase: Phase 0
Study type: Observational

This study evaluates the women cervical samples through molecular tests in order to: 1. Deploy the test careHPV (hybrid capture test) in mobile unities of the Barretos Cancer Hospital to evaluate their performance;